Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation.
The CD34-negative, adherent growing, fibroblast-like canine haematopoietic stem cell line D064 was recently identified as the earliest progenitor population in the bone marrow. D064 cells are predominately quiescent. Quiescence is mediated by the accumulation of the cyclin-dependent kinase inhibitor p27(kip-1)and in parallel, by the downregulation of Cyclin B, leading to an accumulation of quiescent cells in the G(0)/G(1)-phase of the cell cycle. Stem cell factor (SCF), the ligand for the tyrosine kinase receptor c-kit, usually induces differentiation of the CD34-negative stem cells into CD34-positive haematopoietic precursors. SCF also suppresses the expression of c-myc-dependent Cyclin E, which is not transcribed initially, but expression occurs later on. Interleukin 6 (IL-6) instead rather promotes proliferation, but fails to induce proliferation in the majority of CD34-negative stem cells due to no STAT activation in quiescent cells. Nevertheless, the potential of quiescent D064 cells to proliferate eventually, becomes apparent by the low-level expression of IL-6 dependent STAT factors. D064 cells also spontaneously start to express Bax, while Bcl-2 is downregulated in parallel. In summary, CD34-negative haematopoietic stem cells dwell in the marrow or other niches as quiescent cells, until they can respond to autocrine or paracrine growth factor-mediated signals.
Huss
R
R
Institute of Pathology, Ludwig-Maximilians-Universität, Thalkirchner Str. 36, Munich, D-80337, Germany.
Gatsios
P
P
Graeve
L
L
Lange
C
C
Eissner
G
G
Kolb
H J
HJ
Thalmeier
K
K
Heinrich
P C
PC
D000818:Animals; D018952:Antigens, CD34 / Q000378:metabolism; D019556:COS Cells; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000096:biosynthesis; D002455:Cell Division; D002478:Cells, Cultured; D019926:Cyclin B / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004285:Dogs; D015536:Down-Regulation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000502:physiology*; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D050794:STAT1 Transcription Factor; D019089:Stem Cell Factor / Q000502:physiology; D015534:Trans-Activators / Q000378:metabolism*; D014158:Transcription, Genetic; D051028:bcl-2-Associated X Protein
D018952:Antigens, CD34; C494826:BAX protein, human; D018797:Cell Cycle Proteins; D019926:Cyclin B; D004268:DNA-Binding Proteins; D015850:Interleukin-6; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc; D050794:STAT1 Transcription Factor; C494079:STAT1 protein, human; D019089:Stem Cell Factor; D015534:Trans-Activators; D051028:bcl-2-Associated X Protein